Anthony Kim joined the Relief team in November 2021 as Senior Vice President and Head of U.S. Commercial Operations. He is a highly experienced pharmaceutical executive with a successful track record in launch execution, strategic planning and marketing across a variety of indications. Prior to joining Relief he was Vice President, Global Commercial Development at Novocure, where he was responsible for planning and U.S. marketing execution. Before that, he was Executive Director of Marketing at Ignyta (subsequently acquired by Roche), where he led the development of the commercial launches. Earlier in his career, Mr. Kim held positions of increasing responsibility at Alexion Pharmaceuticals, Inc., most recently serving as Director, Head of U.S. Marketing and held various positions at Genentech, with responsibilities as product management, marketing and sales. Mr. Kim holds a B.A. from Harvard University and an MBA from The Wharton School.